These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17424995)

  • 1. [Molecular pharmacology and medicinal chemistry of fibrate].
    Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):108-12. PubMed ID: 17424995
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrate in lipid metabolism disorders].
    Kostner KM; Kostner GM
    Pharm Unserer Zeit; 2007; 36(2):114-9. PubMed ID: 17424996
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin islands and PPAR ligands in platelets.
    Phipps RP; Blumberg N
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):620-1. PubMed ID: 19369654
    [No Abstract]   [Full Text] [Related]  

  • 4. [New targets and drugs for treatment of lipid metabolism disorders].
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):142-8. PubMed ID: 17425000
    [No Abstract]   [Full Text] [Related]  

  • 5. Implication of fibrate therapy for homocysteine.
    Goffin E; Jamar F; Desager JP; Devuyst O
    Lancet; 1999 Oct; 354(9185):1209. PubMed ID: 10513738
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrates, glitazones, and peroxisome proliferator-activated receptors.
    Lalloyer F; Staels B
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):894-9. PubMed ID: 20393155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of fibrates in postprandial lipemia.
    Kolovou GD; Kostakou PM; Anagnostopoulou KK; Cokkinos DV
    Am J Cardiovasc Drugs; 2008; 8(4):243-55. PubMed ID: 18690758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field of confusion: future prospects for fibrate therapy in cardiovascular disease.
    Rosenson RS
    Curr Atheroscler Rep; 2006 May; 8(3):219-22. PubMed ID: 16640958
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nicotinic acid in lipid metabolism disorders].
    Ahmed K; Offermanns S
    Pharm Unserer Zeit; 2007; 36(2):120-5. PubMed ID: 17424997
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrate therapy in patients with metabolic syndrome and diabetes mellitus.
    Dayspring T; Pokrywka G
    Curr Atheroscler Rep; 2006 Sep; 8(5):356-64. PubMed ID: 16901405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nuclear receptors PPARalpha].
    Soska V
    Vnitr Lek; 2006 Jun; 52(6):628-31. PubMed ID: 16871768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrate and its perspective as a drug for metabolic syndrome].
    Tada N
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():622-6. PubMed ID: 17458293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of familial combined hyperlipidemia].
    Bruckert E
    Ann Endocrinol (Paris); 1997; 58(4):297-301. PubMed ID: 9436478
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormal lipid profiles on fibrate derivatives.
    McLeod AJ; Warren RJ; Armitage M
    Lancet; 1996 Jan; 347(8996):261. PubMed ID: 8551900
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs?
    Djouadi F; Aubey F; Schlemmer D; Gobin S; Laforet P; Wanders RJ; Strauss AW; Bonnefont JP; Bastin J
    J Inherit Metab Dis; 2006; 29(2-3):341-2. PubMed ID: 16763897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The action of a fibric acid derivative on lipid metabolism].
    Filip M; Păduraru I; Nechifor M; Dănilă GH; Popovici I; Filip FM; Poşircă F
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):573-6. PubMed ID: 2636755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrates and microvascular complications in diabetes--insight from the FIELD study.
    Ansquer JC; Foucher C; Aubonnet P; Le Malicot K
    Curr Pharm Des; 2009; 15(5):537-52. PubMed ID: 19199980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear peroxisome proliferator-activated receptors and thiazolidinediones.
    Grinberg A; Park KW
    Int Anesthesiol Clin; 2005; 43(2):1-21. PubMed ID: 15795559
    [No Abstract]   [Full Text] [Related]  

  • 20. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.
    Shiri-Sverdlov R; Wouters K; van Gorp PJ; Gijbels MJ; Noel B; Buffat L; Staels B; Maeda N; van Bilsen M; Hofker MH
    J Hepatol; 2006 Apr; 44(4):732-41. PubMed ID: 16466828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.